For example, treatment of ovarian cancer patient tissues ex vivo with the PARPi olaparib increased BRCA1, BRCA2, RAD51, and FOXM1 gene expression, and treatment of the tissues with olaparib and thiostrepton reversed this effect. The gene discussed is FOXM1; the disease is ovarian cancer.